Literature DB >> 25200834

The concentrations of EGFR, LRG1, ITIH4, and F5 in serum correlate with the number of colonic adenomas in ApcPirc/+ rats.

Melanie M Ivancic1, Amy A Irving2, Kelli G Jonakin1, William F Dove3, Michael R Sussman4.   

Abstract

The development of noninvasive methods for early detection of colon cancer is critical for the successful management of this disease. Using a targeted quantitative proteomics technique, we assessed the ability of 12 serum proteins to detect the presence of colonic polyps in the Apc(Pirc) (/+) rat model of familial colon cancer. Serum protein candidates were selected from gene transcripts upregulated in colonic tumors of Apc(Pirc) (/+) rats and from a prior study of serum proteins differentially expressed in mice carrying intestinal adenomas. Proteins were quantified at early stages of polyp formation in a rat cohort monitored longitudinally by colonoscopy over a period of 75 days. Of the 12 proteins monitored at three distinct time points, seven showed differential expression in at least one time point in the serum from Apc(Pirc) (/+) rats compared with wild-type rats. Tumor multiplicity correlated with protein expression changes, and most tumors grew during the study. EGFR, LRG1, ITIH4, and F5 displayed the most robust tumor-associated protein expression changes over time. Receiver operator characteristic analysis using these four proteins resulted in a sensitivity of 100%, a specificity of 80%, and an area under the curve of 0.93 at 135 days of age, when the Pirc rats bore an average of 19 tumors in the colon and seven in the small intestine. The results of this study demonstrate that the quantitative analysis of a panel of serum proteins can detect the presence of early intestinal tumors in a rat model, and provides support for future measurements in humans. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25200834      PMCID: PMC4221466          DOI: 10.1158/1940-6207.CAPR-14-0056

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  43 in total

1.  Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.

Authors:  A Brazma; P Hingamp; J Quackenbush; G Sherlock; P Spellman; C Stoeckert; J Aach; W Ansorge; C A Ball; H C Causton; T Gaasterland; P Glenisson; F C Holstege; I F Kim; V Markowitz; J C Matese; H Parkinson; A Robinson; U Sarkans; S Schulze-Kremer; J Stewart; R Taylor; J Vilo; M Vingron
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

2.  Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women.

Authors:  Jon J Ladd; Tina Busald; Melissa M Johnson; Qing Zhang; Sharon J Pitteri; Hong Wang; Dean E Brenner; Paul D Lampe; Raju Kucherlapati; Ziding Feng; Ross L Prentice; Samir M Hanash
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-25

Review 3.  An international review of the main cost-effectiveness drivers of virtual colonography versus conventional colonoscopy for colorectal cancer screening: is the tide changing due to adherence?

Authors:  Christine Kriza; Martin Emmert; Philip Wahlster; Charlotte Niederländer; Peter Kolominsky-Rabas
Journal:  Eur J Radiol       Date:  2013-08-12       Impact factor: 3.528

4.  Immunohistochemical expression of MMP-7 protein and its serum level in colorectal cancer.

Authors:  Anna Pryczynicz; Mariusz Gryko; Katarzyna Niewiarowska; Violetta Dymicka-Piekarska; Marek Ustymowicz; Maciej Hawryluk; Dariusz Cepowicz; Agnieszka Borsuk; Andrzej Kemona; Waldemar Famulski; Katarzyna Guzinska-Ustymowicz
Journal:  Folia Histochem Cytobiol       Date:  2013       Impact factor: 1.698

5.  Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history.

Authors:  Perry J Pickhardt; David H Kim; B Dustin Pooler; J Louis Hinshaw; Duncan Barlow; Don Jensen; Mark Reichelderfer; Brooks D Cash
Journal:  Lancet Oncol       Date:  2013-06-07       Impact factor: 41.316

6.  ITIH3 is a potential biomarker for early detection of gastric cancer.

Authors:  Poh Kuan Chong; Huiyin Lee; Jianbiao Zhou; Shaw-Cheng Liu; Marie Chiew Shia Loh; Ting Ting Wang; Siew Pang Chan; Duane T Smoot; Hassan Ashktorab; Jimmy Bok Yan So; Khong Hee Lim; Khay Guan Yeoh; Yoon Pin Lim
Journal:  J Proteome Res       Date:  2010-07-02       Impact factor: 4.466

7.  Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group.

Authors:  Melissa K Tuck; Daniel W Chan; David Chia; Andrew K Godwin; William E Grizzle; Karl E Krueger; William Rom; Martin Sanda; Lynn Sorbara; Sanford Stass; Wendy Wang; Dean E Brenner
Journal:  J Proteome Res       Date:  2009-01       Impact factor: 4.466

8.  Revised TN categorization for colon cancer based on national survival outcomes data.

Authors:  Leonard L Gunderson; John Milburn Jessup; Daniel J Sargent; Frederick L Greene; Andrew K Stewart
Journal:  J Clin Oncol       Date:  2009-11-30       Impact factor: 44.544

9.  Discovery and validation of colonic tumor-associated proteins via metabolic labeling and stable isotopic dilution.

Authors:  Edward L Huttlin; Xiaodi Chen; Gregory A Barrett-Wilt; Adrian D Hegeman; Richard B Halberg; Amy C Harms; Michael A Newton; William F Dove; Michael R Sussman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

10.  Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis.

Authors:  Kenneth E Hung; Vitor Faca; Kenneth Song; David A Sarracino; Larissa Georgeon Richard; Bryan Krastins; Sara Forrester; Andrew Porter; Alexandra Kunin; Umar Mahmood; Brian B Haab; Samir M Hanash; Raju Kucherlapati
Journal:  Cancer Prev Res (Phila)       Date:  2009-02-24
View more
  9 in total

1.  LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome.

Authors:  Diana E Ramirez-Ardila; Kirsten Ruigrok-Ritstier; Jean C Helmijr; Maxime P Look; Steven van Laere; Luc Dirix; Els M J J Berns; Maurice P H M Jansen
Journal:  Mol Oncol       Date:  2016-07-25       Impact factor: 6.603

2.  ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.

Authors:  Xiaohan Li; Bo Li; Boan Li; Tongsheng Guo; Zhiqiang Sun; Xiaoxi Li; Lin Chen; Weijiao Chen; Peng Chen; Yuanli Mao; Yanjun Zeng
Journal:  Pathol Oncol Res       Date:  2017-08-21       Impact factor: 3.201

3.  Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers.

Authors:  Melanie M Ivancic; Bryant W Megna; Yuriy Sverchkov; Mark Craven; Mark Reichelderfer; Perry J Pickhardt; Michael R Sussman; Gregory D Kennedy
Journal:  J Surg Res       Date:  2019-10-03       Impact factor: 2.192

4.  LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.

Authors:  Chun-Hua Wang; Min Li; Li-Li Liu; Ruo-Yao Zhou; Jia Fu; Chris Zhiyi Zhang; Jing-Ping Yun
Journal:  Oncotarget       Date:  2015-12-08

5.  Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data.

Authors:  Lazaro Hiram Betancourt; Krzysztof Pawłowski; Jonatan Eriksson; A Marcell Szasz; Shamik Mitra; Indira Pla; Charlotte Welinder; Henrik Ekedahl; Per Broberg; Roger Appelqvist; Maria Yakovleva; Yutaka Sugihara; Kenichi Miharada; Christian Ingvar; Lotta Lundgren; Bo Baldetorp; Håkan Olsson; Melinda Rezeli; Elisabet Wieslander; Peter Horvatovich; Johan Malm; Göran Jönsson; György Marko-Varga
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

6.  Conserved serum protein biomarkers associated with growing early colorectal adenomas.

Authors:  Melanie M Ivancic; Leigh W Anson; Perry J Pickhardt; Bryant Megna; Bryan D Pooler; Linda Clipson; Mark Reichelderfer; Michael R Sussman; William F Dove
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-10       Impact factor: 11.205

7.  Plasma Inter-Alpha-Trypsin Inhibitor Heavy Chains H3 and H4 Serve as Novel Diagnostic Biomarkers in Human Colorectal Cancer.

Authors:  Xiao Jiang; Xiao-Yan Bai; Bowen Li; Yanan Li; Kangkai Xia; Miao Wang; Shujing Li; Huijian Wu
Journal:  Dis Markers       Date:  2019-07-31       Impact factor: 3.434

8.  Evaluation of a biomarker for the diagnosis of pancreas cancer using an animal model.

Authors:  Katsumi Fukamachi; Yoshiaki Hagiwara; Mitsuru Futakuchi; David B Alexander; Hiroyuki Tsuda; Masumi Suzui
Journal:  J Toxicol Pathol       Date:  2019-04-04       Impact factor: 1.628

Review 9.  The utility of Apc-mutant rats in modeling human colon cancer.

Authors:  Amy A Irving; Kazuto Yoshimi; Marcia L Hart; Taybor Parker; Linda Clipson; Madeline R Ford; Takashi Kuramoto; William F Dove; James M Amos-Landgraf
Journal:  Dis Model Mech       Date:  2014-10-02       Impact factor: 5.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.